{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T19:07:41Z","timestamp":1790622461343,"version":"4.1.0"},"reference-count":48,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008530","name":"European Regional Development Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008530","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/j.ejmech.2018.01.002","type":"journal-article","created":{"date-parts":[[2018,1,3]],"date-time":"2018-01-03T08:35:00Z","timestamp":1514968500000},"page":"790-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"special_numbering":"C","title":["Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects"],"prefix":"10.1016","volume":"145","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6192-8721","authenticated-orcid":false,"given":"Pawe\u0142","family":"Zajdel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Kos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Marciniec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grzegorz","family":"Sata\u0142a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Canale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kami\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Ho\u0142uj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Lenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Koralewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Bednarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leszek","family":"Nowi\u0144ski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacek","family":"W\u00f3jcikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W\u0142adys\u0142awa A.","family":"Daniel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Nikiforuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irena","family":"Nalepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Chmielarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Ku\u015bmierczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej J.","family":"Bojarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Popik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.01.002_bib1","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/261717a0","article-title":"Antipsychotic drug doses and neuroleptic\/dopamine receptors","volume":"261","author":"Seeman","year":"1976","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2018.01.002_bib2","series-title":"Diagnostic and Statistical Manual of Mental Disorders","year":"2013"},{"issue":"Suppl","key":"10.1016\/j.ejmech.2018.01.002_bib3","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/BF00442559","article-title":"Clozapine: neuroleptic-induced EPS and tardive dyskinesia","volume":"99","author":"Casey","year":"1989","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2018.01.002_bib4","series-title":"Psychopharmacol","first-page":"245","article-title":"Dopaminergic neuronal system in the hypothalamus","author":"Moore","year":"1994"},{"key":"10.1016\/j.ejmech.2018.01.002_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0022-3565(25)20710-8","article-title":"Classification of typical and atypical antipsychotic drugs on the basis of dopamine D1, D2 and serotonin2 pKi values","volume":"251","author":"Meltzer","year":"1989","journal-title":"J.\u00a0Pharmacol. Exp. Ther"},{"key":"10.1016\/j.ejmech.2018.01.002_bib6","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/npp.2009.176","article-title":"Pimavanserin, a serotonin2A receptor inverse agonist, for the treatment of parkinson's disease psychosis","volume":"35","author":"Meltzer","year":"2010","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/j.ejmech.2018.01.002_bib7","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/S0006-8993(02)03570-9","article-title":"Atypical antipsychotic drugs, quetiapine, iloperidone, and melperone, preferentially increase dopamine and acetylcholine release in rat medial prefrontal cortex: role of 5-HT1A receptor agonism","volume":"956","author":"Ichikawa","year":"2002","journal-title":"Brain Res."},{"key":"10.1016\/j.ejmech.2018.01.002_bib8","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/cn3001125","article-title":"Future directions for serotonin and antidepressants","volume":"4","author":"Artigas","year":"2013","journal-title":"ACS Chem. Neurosci"},{"key":"10.1016\/j.ejmech.2018.01.002_bib9","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.ejmech.2016.09.026","article-title":"The replacement of the 2-methoxy substituent of N-((6,6-diphenyl-1,4-dioxan-2-yl)methyl)-2-(2-methoxyphenoxy)ethan-1-amine improves the selectivity for 5-HT1A receptor over alpha1-adrenoceptor and D2-like receptor subtypes","volume":"125","author":"Del Bello","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib10","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0022-3565(25)38596-4","article-title":"Binding of typical and atypical antipsychotic agents to 5-hydroxytryptamine-6 and 5-hydroxytryptamine-7 receptors","volume":"268","author":"Roth","year":"1994","journal-title":"J.\u00a0Pharmacol. Exp. Ther"},{"key":"10.1016\/j.ejmech.2018.01.002_bib11","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1515\/revneuro-2014-0005","article-title":"The procognitive effects of 5-HT6 receptor ligands in animal models of schizophrenia,","volume":"25","author":"Nikiforuk","year":"2014","journal-title":"Rev. Neurosci."},{"key":"10.1016\/j.ejmech.2018.01.002_bib12","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/FBP.0000000000000132","article-title":"Improvement of ketamine-induced social withdrawal in rats: the role of 5-HT7 receptors","volume":"26","author":"Ho\u0142uj","year":"2015","journal-title":"Behav. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.002_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0066695","article-title":"Effects of the selective 5-HT7 receptor antagonist SB-269970 and amisulpride on ketamine-induced schizophrenia-like deficits in rats","volume":"8","author":"Nikiforuk","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.ejmech.2018.01.002_bib14","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/nrd.2016.28","article-title":"Altering the course of schizophrenia: progress and perspectives","volume":"15","author":"Millan","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.01.002_bib15","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.neuropharm.2011.03.013","article-title":"Psychopharmacological treatment of schizophrenia: what do we have, and what could we get?","volume":"62","author":"Ellenbroek","year":"2012","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2018.01.002_bib16","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1021\/acsmedchemlett.6b00056","article-title":"N1-Azinylsulfonyl-1H-indoles: 5-HT6 receptor antagonists with procognitive and antidepressant-like properties","volume":"7","author":"Zajdel","year":"2016","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2018.01.002_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ejmech.2012.11.042","article-title":"Antidepressant and antipsychotic activity of new quinoline- and isoquinoline-sulfonamide analogs of aripiprazole targeting serotonin 5-HT1A\/5-HT2A\/5-HT7 and dopamine D2\/D3 receptors","volume":"60","author":"Zajdel","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib18","doi-asserted-by":"crossref","first-page":"4537","DOI":"10.1021\/jo9824596","article-title":"A\u00a0user-friendly entry to 2-Iodoxybenzoic acid (IBX)","volume":"64","author":"Frigerio","year":"1999","journal-title":"J.\u00a0Org. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib19","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.3987\/COM-07-11088","article-title":"From haloquinolines and halopyridines to quinoline- and pyridinesulfonyl chlorides and sulfonamides","volume":"71","author":"Ma\u015blankiewicz","year":"2007","journal-title":"Heterocycles"},{"key":"10.1016\/j.ejmech.2018.01.002_bib20","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1016\/S0040-4039(99)00217-8","article-title":"Increased ring closing metathesis activity of ruthenium-based olefin metathesis catalysts coordinated with imidazolin-2-ylidene ligands","volume":"40","author":"Scholl","year":"1999","journal-title":"Tetrahedron Lett."},{"key":"10.1016\/j.ejmech.2018.01.002_bib21","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1021\/cr00028a010","article-title":"Organic synthesis with a diazocarbonyl compounds","volume":"94","author":"Ye","year":"1994","journal-title":"Chem. Rev."},{"key":"10.1016\/j.ejmech.2018.01.002_bib22","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/S1043-9471(05)80049-7","article-title":"Integrated methods for the construction of three dimensional models and computational probing of structure-function relations in G protein-coupled receptors","volume":"25","author":"Ballesteros","year":"1995","journal-title":"Meth. Neurosci."},{"key":"10.1016\/j.ejmech.2018.01.002_bib23","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1124\/pr.114.009944","article-title":"What can crystal structures of aminergic receptors tell us about designing subtype-selective ligands?","volume":"67","author":"Michino","year":"2015","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.ejmech.2018.01.002_bib24","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/j.bmc.2011.12.039","article-title":"Quinoline- and isoquinoline-sulfonamide derivatives of LCAP as potent CNS multi-receptor 5-HT1A\/5-HT2A\/5-HT7 and D2\/D3\/D4 agents: the synthesis and pharmacological evaluation","volume":"20","author":"Zajdel","year":"2012","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib25","doi-asserted-by":"crossref","first-page":"5181","DOI":"10.1016\/j.bmc.2004.07.023","article-title":"Benzimidazole derivatives. Part 5: design and synthesis of new benzimidazole-arylpiperazine derivatives acting as mixed 5-HT1A\/5-HT3 ligands","volume":"12","author":"Lopez-Rodriguez","year":"2004","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib26","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ejmech.2012.07.043","article-title":"The multiobjective based design, synthesis and evaluation of the arylsulfonamide\/amide derivatives of aryloxyethyl- and arylthioethyl-piperidines and pyrrolidines as a novel class of potent 5-HT7 receptor antagonists","volume":"56","author":"Zajdel","year":"2012","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib27","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1021\/jm980420n","article-title":"1-aryl-4-[(5-methoxy-1,2,3,4-tetrahydronaphthalen-1-yl)alkyl]piperazines and their analogues: influence of the stereochemistry of the tetrahydronaphthalen-1-yl nucleus on 5-HT1A receptor affinity and selectivity versus alpha1 and D2 receptors","volume":"42","author":"Perrone","year":"1999","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib28","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/0014-2999(93)90280-U","article-title":"WAY100135: a novel, selective antagonist at presynaptic and postsynaptic 5-HT1A receptors","volume":"237","author":"Fletcher","year":"1993","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.002_bib29","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00213-010-2137-8","article-title":"The role of serotonin in the NMDA receptor antagonist models of psychosis and cognitive impairment","volume":"213","author":"Meltzer","year":"2011","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2018.01.002_bib30","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s002130050165","article-title":"Blockade of phencyclidine-induced hyperlocomotion by olanzapine, clozapine and serotonin receptor subtype selective antagonists in mice","volume":"129","author":"Gleason","year":"1997","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2018.01.002_bib31","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/0166-4328(88)90157-X","article-title":"A\u00a0new one-trial test for neurobiological studies of memory in rats. 1: behavioral data","volume":"31","author":"Ennaceur","year":"1988","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.ejmech.2018.01.002_bib32","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.ejphar.2005.07.002","article-title":"Phencyclidine-induced cognitive deficits in mice are improved by subsequent subchronic administration of clozapine, but not haloperidol","volume":"519","author":"Hashimoto","year":"2005","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.002_bib33","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1124\/mol.63.6.1223","article-title":"3,4-methylenedioxymethamphetamine (MDMA, \u201cEcstasy\u201d) induces fenfluramine-like proliferative actions on human cardiac valvular interstitial cells in\u00a0vitro","volume":"63","author":"Setola","year":"2003","journal-title":"Mol. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.002_bib34","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.pharep.2015.04.005","article-title":"Inhibition of human cytochrome P450 isoenzymes by a phenothiazine neuroleptic levomepromazine: an in\u00a0vitro study","volume":"67","author":"Basi\u0144ska-Ziobron","year":"2015","journal-title":"Pharmacol. Rep."},{"key":"10.1016\/j.ejmech.2018.01.002_bib35","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1016\/S0090-9556(24)15029-5","article-title":"Effect of antipsychotic drugs on human liver cytochrome P-450 (CYP) isoforms in\u00a0vitro: preferential inhibition of CYP2D6","volume":"27","author":"Shin","year":"1999","journal-title":"Drug Metabol. Dispos."},{"key":"10.1016\/j.ejmech.2018.01.002_bib36","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0149-7634(99)00037-8","article-title":"The conditioned avoidance response test re-evaluated: is it a sensitive test for the detection of potentially atypical antipsychotics?","volume":"23","author":"Wadenberg","year":"1999","journal-title":"Neurosci. Biobehav. Rev."},{"key":"10.1016\/j.ejmech.2018.01.002_bib37","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1037\/h0059831","article-title":"A\u00a0behavioral analysis of degree of reinforcement and ease of shifting to new responses in a Weigl-type card-sorting problem","volume":"38","author":"Grant","year":"1948","journal-title":"J.\u00a0Exp. Psychol."},{"key":"10.1016\/j.ejmech.2018.01.002_bib38","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1080\/135468098396242","article-title":"Specific neuropsychological deficits in schizophrenic patients with preserved intellectual fucntion","volume":"3","author":"Elliott","year":"1998","journal-title":"Cogn. Neuropsychiatry"},{"key":"10.1016\/j.ejmech.2018.01.002_bib39","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1523\/JNEUROSCI.20-11-04320.2000","article-title":"Medial frontal cortex mediates perceptual attentional set shifting in the rat","volume":"20","author":"Birrell","year":"2000","journal-title":"J.\u00a0Neurosci."},{"key":"10.1016\/j.ejmech.2018.01.002_bib40","first-page":"289","article-title":"Structure-activity relationship studies of CNS agents. Part 9: 5-HT1A and 5-HT2 receptor affinity of some 2- and 3-substituted 1,2,3,4-tetrahydro-beta-carbolines","volume":"48","author":"Bojarski","year":"1993","journal-title":"Pharmazie"},{"key":"10.1016\/j.ejmech.2018.01.002_bib41","doi-asserted-by":"crossref","first-page":"7116","DOI":"10.1016\/j.bmc.2007.07.029","article-title":"The influence of modifications in imide fragment structure on 5-HT1A and 5-HT7 receptor affinity and in\u00a0vivo pharmacological properties of some new 1-(m-trifluoromethylphenyl)piperazines","volume":"15","author":"Paluchowska","year":"2007","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.01.002_bib42","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1016\/0006-2952(73)90196-2","article-title":"Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction","volume":"22","author":"Cheng","year":"1973","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.01.002_bib43","doi-asserted-by":"crossref","first-page":"3386","DOI":"10.1016\/j.jchromb.2011.09.010","article-title":"In\u00a0vitro metabolic stability and metabolite profiling of TJ0711 hydrochloride, a newly developed vasodilatory \u03b2-blocker, using a liquid chromatography-tandem mass spectrometry method","volume":"879","author":"Huang","year":"2011","journal-title":"J.\u00a0Chromatogr. B. Analyt. Technol. Biomed. Life Sci."},{"key":"10.1016\/j.ejmech.2018.01.002_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1177\/1087057103255988","article-title":"Optimization of a higher throughput microsomal stability screening assay for profiling drug discovery candidates","volume":"8","author":"Di","year":"2003","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2018.01.002_bib45","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s00213-014-3738-4","article-title":"1-aminocyclopropanecarboxylic acid (ACPC) produces procognitive but not antipsychotic-like effects in rats","volume":"232","author":"Popik","year":"2015","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/j.ejmech.2018.01.002_bib46","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.neuropharm.2016.01.035","article-title":"The effects of a 5-HT5A receptor antagonist in a ketamine-based rat model of cognitive dysfunction and the negative symptoms of schizophrenia","volume":"105","author":"Nikiforuk","year":"2016","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.ejmech.2018.01.002_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.pbb.2012.08.006","article-title":"Somatostatin antagonist potentiates haloperidol-induced catalepsy in the aged rat","volume":"103","author":"Ionov","year":"2012","journal-title":"Pharmacol. Biochem. Behav."},{"key":"10.1016\/j.ejmech.2018.01.002_bib48","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.euroneuro.2009.08.001","article-title":"Mazindol attenuates ketamine-induced cognitive deficit in the attentional set shifting task in rats","volume":"20","author":"Nikiforuk","year":"2010","journal-title":"Eur. Neuropsychopharmacol"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418300023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418300023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,29]],"date-time":"2025-06-29T10:15:36Z","timestamp":1751192136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418300023"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,2]]},"references-count":48,"alternative-id":["S0223523418300023"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.002","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel multi-target azinesulfonamides of cyclic amine derivatives as potential antipsychotics with pro-social and pro-cognitive effects","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.01.002","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}